LEADER 01630nam  2200397 a 450 
001 9910701508803321
005 20120710150358.0
035   $a(CKB)5470000002420004
035   $a(OCoLC)782910774
035   $a(EXLCZ)995470000002420004
100   $a20120402d2012      ua             0
101 0 $aeng
135   $aurbn||||a||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aH.R. 1706, the Protecting Consumer Access to Generic Drugs Act of 2009$b[electronic resource] $ehearing before the Subcommittee on Commerce, Trade, and Consumer Protection of the Committee on Energy and Commerce, House of Representatives, One Hundred Eleventh Congress, first session, March 31 2009
210  1$aWashington :$cU.S. G.P.O.,$d2012.
215   $a1 online resource (v, 314 pages) $cillustrations
300   $aTitle from title screen (viewed on Apr. 2, 2012).
300   $aPaper version available for sale by the Supt. of Docs., U.S. G.P.O.
300   $a"Serial no. 111-25."
320   $aIncludes bibliographical references.
517   $aH.R. 1706, the Protecting Consumer Access to Generic Drugs Act of 2009 
606   $aGeneric drugs$xLaw and legislation$zUnited States
606   $aDrugs$zUnited States$vPatents
606   $aRestraint of trade$zUnited States
615  0$aGeneric drugs$xLaw and legislation
615  0$aDrugs
615  0$aRestraint of trade
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910701508803321
996   $aH.R. 1706, the Protecting Consumer Access to Generic Drugs Act of 2009$93484852
997   $aUNINA